News

The U.S. DOGE Service’s push for early retirement and deferred resignation is leading to a federal brain drain, longtime ...
The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in ...
In a meta-analysis, both the 200-mg and 400-mg doses were effective, although the 400-mg dose was more effective in those with moderate-to-severe kidney disease.
The Food and Drug Administration (FDA) announced Friday it had cleared a new test to help diagnose adults with Alzheimer’s ...
A new report says rice sold in U.S. stores contains toxic heavy metals, including arsenic, cadmium, lead and mercury.
The U.S. Food and Drug Administration has cleared Fujirebio Diagnostics' blood test to diagnose Alzheimer's disease, the ...
Bayer Pharmaceuticals' chief operating officer said the head of the top U.S. drug regulator recently reassured industry ...
CHENNAI: In a milestone move, the US Food and Drug Administration has given the green light to the world's first blood test ...
A new report says Health and Human Services Secretary Robert F. Kennedy Jr. will roll back current CDC guidance on COVID ...
The blood test is for the early detection of amyloid plaques associated with Alzheimer’s disease in adult patients ...
The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.
The FDA has approved the Lumipulse Plasma Ratio test, a groundbreaking blood test for early dementia detection. This less ...